deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02811159

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

An Open-Label Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Sponsor: Repros Therapeutics Inc.

Conditions Uterine Fibroids
Interventions Telapristone acetate
Updated 9 times since 2017 Last updated: Jun 20, 2019 Started: Jul 26, 2016 Primary completion: May 4, 2017 Completion: May 4, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Business decision

Other terminated trials from Repros Therapeutics Inc.

More terminations from Repros Therapeutics Inc.

This PHASE2 trial investigates Uterine Fibroids and is currently terminated or withdrawn. Repros Therapeutics Inc. leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotActive Not Recruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotTerminated~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotTerminated~Jul 2018 – ~Jul 2019 · 12 months · monthly snapshotTerminated~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jul 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jul 2018 — Jul 2019 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Jul 2018 [monthly]

    Terminated PHASE2

  2. Aug 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  3. Feb 2017 — Aug 2017 [monthly]

    Active Not Recruiting PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Repros Therapeutics Inc.
Data source: Repros Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations